Introduction
Human immunodeficiency virus (HIV), the aetiological agent of AIDS ( Barr6-Sinoussi et al., 1983; Gallo et al., 1984; Levy et aI., 1984) , primarily infects CD4 + T lymphocytes and cells of the monocyte-macrophage lineage e:<pressing the CD4 cell surface glycoprotein (Dalgleish et al., 1984; Klatzmann et al., 1984; Maddon et al., 1988) . The CD4 molecule acts as a receptor for HIV. The major virus envelope glycoprotein, gp120, attaches to CD4 molecules expressed on the host cell surface. After binding, HIV is internalized via direct, pHindependent fusion of the viral and cell membranes (McClure et al., 1988; Stein et al., 1987) . However, attachment of HIV to CD4 on target cells is not sufficient for fusion. Interaction of gp160-expressing cells with neighbouring cells bearing surface CD4 molecules is also required for syncytium formation. Syncytium formation and subsequent generalized cell fusion have been reported as potentially important mechanisms of virus-induced cytotoxic effects (Koot et al., 1993 ; Lifson et al., 1986a, b; Sodroski et al., 1986) .
Author for correspondence: We previously reported that the addition of anti-L929 cell antiserum to a culture medium enhanced syncytium formation in Newcastle disease virus (NDV)-infected L929 cells. This finding suggested that factors that are capable of regulating virus-mediated cell fusion are present on the surface of host cells (Ito et al., 1987a) . In addition, we isolated monoclonal antibodies (MAbs) capable of enhancing cell fusion in NDVinfected HeLa cells (Ito et al., 1992) . These MAbs immunoprecipitated two glycoproteins, gpS0 and gp135, which were detected on the surface of HeLa cells. These molecules appeared to regulate NDV-mediated cell fusion. Therefore, gpS0 and gp135 were designated fusion regulatory protein (FRP)-I and FRP-2, respectively (Ito et al., 1992) . Anti-FRP-1 antibodies were found to induce homotypic cell aggregation and multinucleated giant cell formation of monocytes lacking fusogen . We recently demonstrated that FRP-1 and FRP-2 molecules are identical to the 4F2/CD98 heavy chain and the a3 subunit of integrin, respectively (Ohgimoto et al., 1995; Ohta et al., 1994) .
The U2ME-7 cell line is derived from CD4 + U937 cells transfected with the HIV gpI60 gene. The expression of gp 160 is induced using cadmium chloride (Koga et al., 1990) . However, syncytium formation was not observed at any time after the induction of HIV gp160 (Koga et at., 1990) . When U2ME-7 cells treated with cadmium chloride (U937/gp160 cells) were cultured in the presence of anti-FRP-I MAb or anti-FRP-2 MAb, polykaryocyte formation was observed (Ohta et a]., 1994) . When either anti-CD4 (Leu3a, T4, Hu-TH/I, OKT4) antibody or anti-HIV gp120 (0"Sfl, A4-33, KDI053) antibody was added to culture fluids of U937/gpI60 cells together with MAb 4-5-i, the antibodies other than OKT4 inhibited anti-FRP-1 MAb-induced cell fusion. However, induction of cell fusion by anti-FRP-1 MAb was not due to the enhancement of HIV gp120 or the CD4 molecule. Thus, these findings suggest that MAbs directed against FRP-1 and FRP-2 enhance the susceptibility to HIV-mediated cell fusion. Furthermore, anti-FRP-1 MAbs induced cell fusion in TALL-1 cells persistently infected with HIV (Ohta et al., 1994) .
In the present study, we investigated the biological activity of previously reported and newly isolated anti-FRP-1/4F2/ CD98 MAbs. Some of these MAbs showed inhibitory activity against FRP-1 system-mediated cell fusion, indicating that the FRP-1/CD98 molecule is capable of either activating or inhibiting cell fusion, depending on whether the stimulant is an activating or an inhibiting anti-FRP-1 MAb. Thus, FRP-1/ CD98 is a multipotential molecule. The inhibiting anti-FRP-1 MAb also blocked FRP-2-mediated cell fusion. Furthermore, fibronectin, the extracellular matrix for FRP-2, and the antibody directed against the fll subunit of FRP-2 inhibited FRP-1-and FRP-2-mediated cell fusion. Interestingly, the steric position of FRP-2 is close to that of FRP-1 on the surface of U2ME-7 cells. These results indicate that these systems do not function independently. Instead, it appears that 'cross-talk' occurs.
Hethods
• Cells. U937-2 (CD4 + U937 ceils), U2ME-7 cells (U937-2 cells transfected with the HIV gpI60 gene), JME2 (Jurkat cells transfected with HIV gpl60 gene) and HeLa cells were cultured in Dulbecco's modified Eagle's medium or Eagle's MEM fortified with 10 % fetal calf serum. The properties of U2ME-7 and JME2 cells have been described previously (Koga et al., 1990) . In this study, we call U2ME-7 cells treated with cadmium chloride and JME2 cells treated with cadmium chloride U937/gp160 and Jurkat/gpI60 cells, respectively.
• Antibodies. Anti-FRP MAbs (4-5-1, 7-2-1 and 6-1-13) have been described previously (Ito et al., I992) . Anti-integrin ill, f12, f13 and CD44 (the human heterotypic adhesion receptor, PIG12) antibodies were purchased from Locus, anti-integrin ~4 antibody from Telios and anti-o¢3 (PIBS) antibody from Oncogene Science. Anti-LFA-1 (CDlla), CDlIb and CDllc antibodies were purchased from Cosmo Bio. Anti-4F2/CD98 antibodies 4F2, HBJ127 and H227 were kindly donated by B. F. Haynes (Duke University, Durham, N.C., USA), Y. Hashimoto (Tohoku University, Sendal, Japan) and M. Nakao (Kurume University, Kurume, Japan), respectively. Anti-human parainfluenza virus 4A NP MAb (3B) was used as the control antibody.
• Isolation of peripheral blood mononuclear cells (PBMCs) and monocytes. PBMCs were isolated from the heparinized whole blood of healthy human volunteers using Ficoll-Hypaque density gradient centrifugation (Tabata et al., 1995a) . PBMCs at the interface were collected and suspended in RPMI-1640 with I0% fetal calf serum. Adherent monocytes were obtained from PBMCs by attachment to tissue culture dishes. The purity of the monocytes (CD 14 + cells) according to the Ficoll-Hypaque and adherence techniques was approximately 85-90%. The viability of the adherent cells after removal using a cell scraper (Falcon) instead of EDTA was greater than 98 %, as measured by trypan blue exclusion. Instead of human serum, monocytes were cultured in RPMI-1640 supplemented with 10% fetal calf serum, since in a previous study using human serum, spontaneous giant cell formation of monocytes was observed (Tabata et al., 1995a) . Under the present experimental conditions using fetal calf serum, spontaneous giant cell formation was only rarely detected during the 4 weeks of monocyte cultivation.
• Production and isolation of hybridoma cell lines. The procedures for preparation of MAbs were similar to those described previously (Tsurudome et al., 1989) . In brief, three mice (C3H/He) were immunized with human FRP-i/CD98-expressing L929 cells and their spleen cells were fused with SP~/°-Ag-14 myeloma cells. The culture fluids of hybridoma cells were screened by ELISA. Cultures of interest were then cloned by soft agar colony formation and cloned further by limiting dilution.
• ELISA. ELISA was performed as described previously, except that human FRP-1/4F2-expressing L929 cells (Ito et al., 1987b) and peroxidase-conjugated goat anti-mouse Ig (dilution 1:2000; Cappel Laboratories) were used as the coating antigen and the secondary serum, respectively.
• Isotopic labelling, radioimmunoprecipitation assay (RIPA) and SDS--PAGE. Isotopic labelling of HeLa cells, RIPA and SDS-PAGE were performed as described previously (Ito et al., 1989) . • Conjugation of MAbs. MAbs 4-5-1 and 7-2-1 were conjugated with fluorescein isothiocyanate (FITC; isomer I) on Celite. FITC solution was slowly added to a solution of MAb 4-5-1 or 7-2-1 (1 mg/ml, pH 8-5) and the reaction was performed at 4 °C for 10 h. The mixture was loaded into a P-10 column equilibrated with PBS. The first yellow fraction was harvested and dialysed against PBS overnight. Specificity was confirmed using MAb-reactive cells (FL and HeLa) and non-reactive cells (BHK, L929 and COPS).
• Flow cytometry analysis. Two to five x I0 ~ cells were incubated with 10 gl F[TC-conlugated anti-FRPs and/or phycoerythrin-conjugated marker MAbs for 30 rain at 4 °C, fixed with FACS Lysing Solution (Becton Dickinson) and washed twice in Cell Wash (Becton Dickinson). Immunofluorescent-stained cells were analysed on a FACScan (Becton Dickinson) using Consort 30 software (Becton Dickinson).
• Aggregation and fusion rates. Cell aggregation and fusion rates were measured using three methods. First, in order to determine the degree of cell aggregation or fusion of U937/gp160 cells and monocytes, all fields in two wells were subjectively evaluated by two or three observers. Cell aggregation scores ranged from' -' to '4 + ', where' -' indicated that virtually no cells were observed to aggregate in clusters, ' 1 +' indicated that < 30% of the cells were observed in loose clusters, '2 + ' indicated that ~ 80 % of the cells had formed loose clusters, ' 3 + ' indicated that > 80 % of the cells were observed in compact aggregates, and '4 + ' indicated that > 90% of the cells had formed large compact clusters. CelI fusion scores also ranged from '-' to '4+ '; '-', no detectable syncytia; '1+', that the diameter of the syncytium was < 30 gm; '2 + ', syncytium diameter 30-60 gm; '3 -4-', syncytium diameter 60--80 ~m; '4+ ', syncytium diameter > 80 gm. In order to evaluate fusion of HeLa cells, cell fusion scores ranged from' -' to' 4 +' : ' -' indicating < 2%; '1 + ' indicating 2 to 25 %; '2 + ' indicating 25 to 50 %; ' 3 + ' indicating 50-75 %; and ' 4 + ' indicating > 75 % fusion.
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• Drugs and chemical reagents. Fibronectin prepared from pooled plasma was purchased from CappeI and Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro, a synthetic peptide, was purchased from Sigma.
Results

Isolation of new MAbs directed against F R P -1 / C D 9 8 molecules and biological activity of a n t i -F R P -1 / 4 F 2 MAbs
Recently, we established murine L929 cells that constitutively express human FRP-1/CD98 molecules (Ohgimoto et al., 1995) . In the present study, we attempted to isolate new MAbs directed against the human FRP-I/CD98 molecule using human FRP-l-expressing L929 cells as antigens. Since L929 cells are derived from C3H/He mice, these mice were immunized three to five times with the FRP-l-expressing L929 cells, following which two hybridoma clones were isolated ( Fig. 1 ). Finally, we obtained four new MAbs directed against FRP-1/4F2 : 4-5-1, 6-1-13, 18-1-2 and 38-2-2. We investigated the biological activities of these MAbs and of three donated MAbs directed against FRP-1/4F2 (4F2, HBJ127 and H227; Table 1 and Fig. 2 ). The isotypes of all anti-FRP-1/CD98 MAbs except 18-1-2 and 38-2-2 were IgG1; 18-1-2 and 38-2-2 were IgG2a. MAbs 4-5-1, 6-1-13 and HBJ127 induced aggregation of U937/gp 160 cells and monocytes, whereas 38-2-2, 4F2 and H227 induced aggregation of monocytes but not of U937/gp160 cells, MAb 18-1-2 did not induce aggregation in monocytes or U937/gp160 cells. iiiiiiiiii!ililililiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii iiii i iii iiii !i ii!ii MAbs were reported to recognize a different epitope (Nakao et al., 1993) . MAb 38-2-2 showed a slight enhancing effect on NDV-induced fusion of HeLa ceils, induced a low degree of monocyte fusion, but induced no fusion in U937/gp160 cells, whereas 18-1-2 induced no cell fusion in U937/gp160 cells and monocytes, and showed no enhancing effect on NDVinduced cell fusion.
Effects of anti-FRP-1 HAbs on fusion of Jurkat/gp160 cells
Subsequently, the effects of anti-FRP-1 MAbs on fusion of Jurkat/gp160 cells were investigated. The JMEg cell is a CD4 + T cell line transfected with the HIV gpI60 gene, in which the expression of gp160 is induced using cadmium chloride (Koga et al., 1990) . After the induction of HIV gpI60, JME2 cells formed syncytia (Fig. 3) . When JME2 cells were cultured in the absence of cadmium chloride, aggregation of cells occurred but syncytium formation was not observed. When JME2 cells were cultured in the presence of 10 i~M-cadmium chloride (Jurkat/ gpI60 cells), strong cell aggregation was induced within 1-2 h, but these aggregates became loose approximately 6 h after incubation. Furthermore, polykaryocytes began to appear approximately 6 h after cadmium stimulation and increased in quantity until approximately 20 h. Balloon cells were observed after approximately 15 h. When Jurkat/gp160 cells were cultured with either 4-5-I or HBJ127, cell aggregation was very strong. These aggregates had a cord-like appearance and did not loosen. Intriguingly, the aggregates of Jurkat/gpl60 cells did not loosen in the presence of anti-FRP-1 MAbs, with the exception of 18-1-2. Four anti-FRP-1 MAbs (38-2-2, HBJ127, 4F2 and H227) suppressed syncytium formation in Jurkat/gp160 cells ( Fig. 3 ; Table 1 ).
Suppression of enhancing anti-FRP-1 MAb-induced fusion of U937/gp160 ceils by inhibitory anti-FRP-1 HAbs
When 6-1-I3 was added to the culture fluid of U937/gp160 cells, extensive cell aggregation was induced within 1-2 h. These aggregates loosened approximately 2-3 h after incubation (Fig. 4a) . Thus, 6-1-13 does not induce fusion in U937/gp160 cells (Fig. 4a ). In the next experiment, the effects of 6-1-13 on the biological activity of 4-5-1 were studied. U937/gp 160 cells were incubated at 37 °C in the presence of 4-5-1 (5 I~g/ml) together with various concentrations of 6-I-13. The degree of cell aggregation and fusion was examined at regular intervals. MAb 6-1-13 interfered with the induction of cell aggregation and fusion by 4-5-1 (Fig. 4a ). Furthermore, when 6-1-13 was added to culture fluids after cell aggregation was established, the aggregates loosened and induction of polykaryocyte formation was inhibited (Fig. 4 a) . Similarly, the effects of anti-FRP-1/4F2 MAbs on the biological ability of activating MAbs (4-5-I and HBJ127) were investigated (Table  1 ; Fig. 4b, c, d, e ). When U937/gp160 cells were incubated in the presence of either 4-5-1 or HBJ127 together with 4F2, both cell fusion and aggregation were suppressed (Fig. 4b, e ), indicating that 4F2 competes with the biological activity of 4-5-1 and HBJ127. MAb 6-1-13 suppressed formation of polykaryocytes, but did not suppress aggregation of U937/ gpI60 cells induced by HBJ127 (Table 1) . Moreover, when H227 was added to the culture fluid of U937/gp160 cells incubated with HJB127, induction of both cell aggregation and fusion was inhibited ( Fig. 4 e) whereas H227 did not affect the biological activity of MAb 4-5-1 (Table 1) . HBJ127 did not induce polykaryocyte formation in monocytes (Table 1) but did interfere with the induction of monocyte fusion by 4-5-1 (data not shown). When 38-2-2 was added to the culture fluid of U937/gp160 cells together with 4-5-1 or HBJ127, it showed no effect on cell aggregation, but suppressed both 4-5-1 and HBJI27-induced cell fusion, even when added 3 h after the cells were incubated with 4-5-1 or HBJ127 ( Fig. 4d ; Table  I ). Conversely, 18-I-2 did not affect 4-5-1 or HBJI27-induced fusion or aggregation of U937/gpI60 cells ( Fig. 4c ; Table 1 ).
Suppression of anti-FRP-2 MAb-induced fusion of U937/gp160 cells by 6-1-13, an inhibitory anti-FRP-1 MAb
When U937/gp160 cells were cultured in the presence of anti-FRP-2 MAb (7-2-1) together with 6-1-I3, induction of cell 75; aggregation and fusion by MAb %2-1 was suppressed (Fig.  4f) . When 6-1-13 was added to the culture fluid of U937/ gp160 cells together with 7-2-1, after cell aggregation had begun, the aggregates loosened and the formation of syncytia was blocked (Fig. 4f) . These findings indicate that induction of cell fusion by anti-FRP-2 MAb is blocked by an inhibitory anti-FRP-1 antibody. -FRP-l-enhanced fusion by  fibronectin, an extracellular matrix for FRP-2, anti-ill  subunit and anti-~3 subunit of FRP-2 
Suppression of anti
antibody
In a previous study, we demonstrated that a MAb directed against fll integrin, a partner of a3 integrin, and fibronectin, an extracellular matrix for FRP-2, inhibited syncytium formation in U937/gp160 cells induced by 4-5-I or 7-2-1 (Ohta et al., 1994) . In the present study, we investigated the effects of various antibodies (anti-fll-integrin, -fl3-integrin, -~3-integrin, -a4-integrin, -CD 1i a, -CD 1 lb, -CD 11 c and -CD 18 antibodies) and extracellular matrices (fibronectin, fibronectin fragment, laminin and collagen) on the induction of aggregation and fusion of U937/gp160 cells by HBJ127. Ceil fusion was blocked by both the anti-ill integrin antibody and fibronectin, although cell aggregation was not influenced by either of these reagents (data not shown). Subsequently, the effects of various antibodies and extracellular matrices on the enhancement of NDV-mediated polykaryocyte formation in U937-2 cells induced by MAb 4-5-1 were investigated. Anti-flI integrin completely suppressed and anti-a3 integrin antibody (PIBS) partially suppressed enhancement of NDV-mediated cell fusion by 4-5-1, whereas anti-fl3 and -~4 integrins, CDIla, CDllb, CDllc, CDI8 and CD44 MAbs did not influence this enhancement (data not shown). In addition, fibronectin partially blocked this enhancement. Laminin, collagen type IV and an oligopeptide containing the RGD motif had no effect on NDV-mediated cell fusion (data not shown). These results indicate that the induction of cell fusion by anti-FRP-I MAb is blocked by antibodies directed against a partner (1/1 or a3 integrin) of FRP-2 (VLA-3), or by fibronectin, an extracellular matrix for FRP-2. However, an oligopeptide containing the RGD (Arg-Gly-Asp) sequence did not affect cell fusion induced by anti-FRP MAbs, indicating that the inhibitory effect of fibronectin is unrelated to that of the RGD sequence.
Competitive binding assay between FRP-1 and FRP-2 systems
Competitive binding assays between 4-5-I and the other anti-FRP-1 MAbs were performed in order to determine the epitopes recognized by these MAbs. Two x 105 U2ME-7 or HeLa cells were preincubated at 4 °C with 4-5-1, 6-1-13, 38-2-2, 18-1-2, 4F2, HBJI27 or H227, and then FITC-conjugated MAb 4-5-1 was added to the cell suspensions, 6-1-I3 competed with the binding of 4-5-1 to U937 or HeLa cells (Fig. 5a i) , but the other MAbs did not (Fig. 5 a, ii, iii; Table I ). Subsequently, competitive binding assays between anti-FRP-1 and anti-FRP-2 MAbs were performed in order to investigate steric relationships between FRP-1 and FRP-2. U937 or HeLa cells were preincubated at 4 °C with anti-ill integrin, anti-a3 integrin or fibronectin, following which FITC-conjugated 4-5-I was added to the cell suspensions. These inhibitors did not compete with the binding of 4-5-1 to U937 or HeLa cells (data not shown). In the same manner, U937 or HeLa cells were preincubated at 4 °C with MAb 4-5-1, 6-1-13, anti-ill integrin or anti-a3 integrin MAb for 30 rain, following which FITCconjugated anti-ill integrin or anti-~3 integrin MAb was added to the cell suspensions. Anti-FRP-1 MAbs did not interfere with the binding of anti-ill integrin antibody to U937 or HeLa cells (data not shown). The anti-ill integrin MAb did not interfere with the binding of 7-2-1 to U937 cells (data not shown). However, both 4-5-1 and 6-1-13 competed with the binding of anti-~3 integrin antibody (MAb 7-2-1) to U937 cells ( Fig. 5 b) , suggesting that FRP-2 is in close proximity to FRP-1 on the surface of U937 cells. Conversely, blocking of anti-a3 integrin MAb binding by anti-FRP-I MAbs was not evident on the surface of HeLa cells, and anti-a3 integrin MAb did not interfere with the binding of anti-FRP-I MAb to the surface of HeLa cells (data not shown).
Additive effects of anti-FRP-1 and anti-FRP-2 HAbs on NDV-induced fusion of HeLa cells
Since competitive binding to the surface of HeLa cells between anti-FRP-1 and anti-FRP-2 MAbs was not observed, we investigated whether these MAbs produced additive effects on NDV-induced cell fusion in HeLa cells. HeLa cells (approximately 10 ~ cells per well in a 96-multiwell dish) were infected with NDV at an m.o.i, of 1. The cells were incubated in MEM supplemented with 5 % fetal calf serum and anti-FRP-2 and/or FRP-1 MAb was added to the culture fluids after adsorption. We used MAbs showing slight or no enhancing effect on NDV-induced cell fusion. When NDV-infected HeLa cells were incubated in the presence of 7-2-1 (anti-FRP-2 MAb) together with MAb 4F2, H227 or 38-2-2, a distinct additive effect on NDV-induced ceil fusion was detected (data not shown).
Discussion
HIV isolates obtained during the early asymptomatic stage of infection and those obtained from patients with AIDS or AIDS-related complex are reported to be phenotypically distinct (Connor eta] ., I994; Schuitemaker et at, , I99I) . Isolates obtained during the early stages of infection do not induce syncytia in cell culture, are not transmissible to cell lines and retain the capacity to replicate in primary macrophages (Connor eta]., 1994; Schuitemaker et al., 1991) . During the later stages of infection, variants appear that induce syncytia, are transmissible to permanent cell lines and no longer have the capacity to replicate in macrophages (Connor et al., 1994; IP: 54.70.40.11 On: Sun, 30 Dec 2018 11:36:25 !i! ii i ii ii i i i i;:i:ii!i iiii i iiiiiiii i ii ! i6 ::i i. i !ii.i iJi.ii. Schuitemaker et aI., 1991 Schuitemaker et aI., , 1992 McNearney et aI., 1992; Zhang eta]., 1993; Zhu et a/., 1993) . The appearance of syncytium-inducing variants is associated with CD4 + T cell depletion and a more rapid progression to AIDS (Koot eta]., 1993 ; Schuitemaker et al., 1992; Zhu eta]., 1993 ; Fouchier eta[., 1992; Tersmette eta]., 1989) . These findings suggest that HIVmediated cell fusion of infected cells with neighbouring cells to form multinucleate syncytia contributes to the pathogenic effects of HIV.
It is now accepted that HIV-I infection of CD4 + T lymphocytes results in CPE. However, the manner in which this effect is mediated remains unclear. Several hypotheses have been proposed to explain HIV-l-induced CD4 + T cell depletion. Recently, several investigators have suggested that HIV infection induces apoptosis, thereby leading to CD4 + T cell depletion in vivo (Terai et aI., 1991) . Intracellular HIV gp120 and CD4 complex formation (Hoxie et al., 1986; Koga et aI., 1991) , HIV-mitochondrial interaction (Somasundaran et a] ., I994) and cytokine-mediated cell death (Matsumaya eta/., 1991; Rosenberg & Fanci, 1990) have also been implicated in HIV-induced cell lysis. Multinucleate giant cell formation is the most prominent cytopathogenic effect induced by HIV in vitro, and fusion of infected cells with uninfected cells has been suggested as one of the major mechanisms involved in ceil death and depletion of CD4 + T cells in vivo (Lifson eta/., 1986a; Sodroski et aI., 1986) . Fusion is mediated by the envelope glycoprotein of the virus, which consists of two subunits, gp120 and gp41, derived from a single precursor, gp160. The binding site for the CD4 molecule is located on gp120, while the region responsible for membrane fusion is located at the N terminus of gp41 (Maddon et aI., 1988; Ashorn et al., 1990) .
FRPs are newly defined cell-surface molecules that enhance/ induce HIV-mediated cell fusion (Ito eta]., 1992) . In a previous study, we concluded that FRP-1 is identical to the heavy chain subunit of 4F2/CD98 based on the following results: (i) the Nterminal amino acid sequence of FRP-1 is identical to that of the 4F2/CD98 heavy chain; (ii) both FRP-1 and 4F2/CD98 are heterodimeric glycoproteins composed of an 80--90 kDa glycosylated heavy chain and a 35-40 kDa non-glycosylated light chain (Ohta et al., 1994; Bron et al., 1986; Haynes et al., 1981; Helmer & Strominger, 1982; Spagnoll et al., 1991; Yagita et al., 1986a) ; (iii) HBJ127, an anti-heavy chain subunit of 4F2/CD98 MAb, induces the formation of multinucleate giant cells in U937/gp160 cells and treatment of monocytes with other antibodies (4F2, H227) directed against 4F2/CD98 results in polykaryocyte formation; (iv) 4F2/CD98 is detected on monocytes and activated lymphocytes (Haynes et at., I981; Yagita et al., I986 b; Hashimoto eta[., 1983) , whereas FRP-1 is expressed selectively on monocytes but not on resting lymphocytes (Tabata et aI., 1995 a) , and lymphocytes that are activated with Concanavalin A or interleukin 2 strongly express FRP-1; (v) anti-FRP-1 MAbs react with L929 cells transiently or constitutively expressing 4F2/CD98 molecules;
(vi) FRP-1 is selectively expressed in specialized organs and tissues (Tabata et a] ., 1995 b) and its distribution suggests that the expression of FRP-1 is related to proliferation, peptide/ protein secretion and cell fusion. Furthermore, when L929 cells constitutively expressing the 4F2/CD98 heavy chain are infected with NDV and are further incubated in the presence of anti-FRP-1 MAbs, giant polykaryocytes appear. Taken together, these events demonstrate that the 4F2/CD98 molecule is involved in the regulation of membrane fusion. The 4F2/CD98 gene is a member of the family of growth-related genes characterized by low-level constitutive expression in resting cells and high-level expression following cell activation or neoplastic transformation (Hashimoto et al., 1983 ; Patterson et a]., 1984; Quackenbush et a]., 1987; Teixeira eta]., 1987) . Despite considerable research and molecular cloning of the heavy chain component, the functions of the 4F2/CD98 molecule are not well understood. Our previous study (Ohgimoto et aI., 1995) indicated that anti-FRP-1 MAb activates the FRP-1 molecule and that this molecule can transduce the cell fusion-enhancing signal into cells.
In the present study, we isolated new MAbs directed against the FRP-1/CD98 molecule, and the biological activity of seven anti-FRP-1/CD98 MAbs was investigated. Several anti-FRP-I/CD98 MAbs showed inhibitory activity against HIV gp160-mediated cell fusion induced by activating anti-FRP-1 MAbs. Interestingly, even when inhibiting anti-FRP-1 MAbs were added to culture fluid after cell aggregation was established by activating MAbs, induction of polykaryocyte formation was inhibited. However, loosening of the cell aggregates depended on the inhibiting MAbs used. These results indicate that the FRP-1/CD98 molecule is capable of either activating or inhibiting cell fusion, depending on whether an activating or inhibiting anti-FRP-1 MAb is used as the stimulant. Thus, FRP-1/CD98 is a multipotential molecule. MAb 5-1-13, an inhibiting anti-FRP-1 MAb, also blocked FRP-2-mediated cell fusion. Furthermore, the antibody directed against the flI subunit of FRP-2, and fibronectin, an extracellular matrix of FRP-2, inhibited FRP-1-and FRP-2-mediated cell fusion. Interestingly, FRP-2 is in close proximity to FRP-1 on the surface of U2ME-7 cells. These results indicate that the two systems do not function independently. Instead, it appears that 'cross-talk' occurs.
MAb 6-1-13 enhanced cell fusion of HeLa cells infected with NDV, but no fusion was observed in U937/gp160 cells. We examined whether this was due to a difference in the host cells (HeLa or U937-2 cells) or in the infected (transfected) virus (NDV or HIV). When HeLa-CD4 and U937-2 cells infected with NDV were incubated in the presence of MAb 6-1-13, polykaryocyte formation in these two cells was enhanced (K. Okamoto, S. Ohgimoto & Y. Ito, unpublished results) . MAb 6-I-13 did not enhance fusion in HeLa-CD4 cells cocultured with U937/gp160 cells (K. Okamoto, S. Ohgimoto & Y. Ito, unpublished results) . HBJ127 enhanced or induced fusion of HeLa cells infected with NDV or U937/gp160 cells, !75" respectively, whereas HBJI27 suppressed polykaryocyte formation in blood monocytes. However, the molecular mechanisms by which this anti-FRP-1/CD98 MAb enhances or suppresses polykaryocyte formation according to the experimental conditions are not well understood.
In conclusion, FRP-1 is a multifunctional molecule and HIVmediated cell fusion can be regulated by modification of the FRP-1 system. Furthermore, the FRP-1 and FRP-2 systems 'cross-talk' in regulating membrane fusion.
